WCM
GRTS

Wildcat Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Wildcat Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-23,902
Closed -$206K – 36
2019
Q3 		$206K Sell
23,902
-170,597
-88% -$1.72M 0.09% 25
2019
Q2 		$2.17M Hold
194,499
– – 0.94% 19
2019
Q1 		$2.59M Sell
194,499
-1
-0% -$13 1.52% 13
2018
Q4 		$3M Hold
194,500
– – 1.98% 9
2018
Q3 		$2.77M Buy
+194,500
New +$2.77M 2.14% 9

Other funds holding GRTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Wildcat Capital Management's GRTS Position: Q4 2019 in Review

Wildcat Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2019, closing a stake of 23,902 shares — an estimated $206K sold.

Wildcat Capital Management first reported a position in GRTS in Q3 2018 and held it in 5 quarters. The position peaked at $3M in Q4 2018. 56 funds tracked by Wall St. Rank hold GRTS as of Q4 2019.

  • Wildcat Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Wildcat Capital Management sold 23,902 Gritstone bio, Inc. Common Stock shares in Q4 2019, an estimated $206K.
  • Wildcat Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
  • Wildcat Capital Management's Gritstone bio, Inc. Common Stock position peaked at $3M in Q4 2018.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2019.

Based on Wildcat Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.